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Editorial Comment 
How Accurate Is Thallium purposes, depends on which of the alternative, opposing 
Exercise Testing for the Diagnosis 
explanations is true: 1) thallium stress testing has sufficiently 
low true specificity to make it of limited value in a population 
of Coronary Artery Disease?* 
K. LANCE GOULD, MD, FACC 
Houston, Texas 
The report by Iskandrian et al. (1) in this issue of the Journal 
contains startling data definitively answering the single most 
important current question about thallium exercise testing- 
how accurate is it? Although the sensitivity and specificity of 
exercise thallium imaging in earlier published reports (2-4) 
are 80% to 90% in symptomatic patients, more recent studies 
(5-10) report a sensitivity of 70% to 85% and a specificity of 
50% to 60% in both symptomatic (5-7) and asymptomatic 
(8,9) subjects or those with atypical presentations (lo), 
consistent with the results of lskandrian et al. (1). 
Reasons for low specificity of thallium stress test. One 
explanation proposed for low specificity in recent reports is 
that patients with a negative thallium stress test no longer 
undergo cardiac catheterization (6). The catheterized sub- 
jects in such a study would then be biased by this exclusion 
of normal subjects, thereby skewing the study group toward 
a higher prevalence of disease. According to Bayes’ theo- 
rem, as the study population is skewed toward greater 
prevalence of disease, the post-test probability of having no 
disease with a normal test or observed test specificity 
decreases in that population (11,12). The second argument 
made in support of this point of view is that the “normalcy 
rate” for exercise thallium single photon emission computed 
tomography (SPECT) is about 90% in uncatheterized pa- 
tients having ~5% probability of coronary artery disease by 
virtue of young age and no risk factors or family history (6). 
The fact of low specificity at 50% to 60% reported in 
recent studies including that of Iskandrian et al. (1) is not 
disputed (5-10). The explanation for this low specificity, and 
therefore the value of thallium stress testing for diagnostic 
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characterized by moderate prevalence of disease (10% to 
30%) in recent studies and is therefore not economically or 
medically appropriate, or 2) thallium stress testing is so good 
that it excludes so many normal subjects from cardiac 
catheterization in current study populations that the cathe- 
terized population of recent studies is now skewed toward 
high prevalence and low reported apparent specificity be- 
cause normal subjects are no longer being catheterized. 
The currently reported low specificity of 50% to 60% is 
unlikely to be due to referral bias, as indicated by the Bayes’ 
theorem graph in Figure 1A (11,12). Let us hypothesize 
generously in favor of exercise thallium SPECT that its true 
sensitivity and specificity are both 90%. Then let us ask 
whether all the data fit this hypothesis, thereby making it 
true or false. If the observed post-test probability of disease 
for a normal noninvasive test is 50% in a study population, 
the apparent specificity in the study population would be 
50% (with 50% having a false positive result). The referral 
bias hypothesis proposed to explain this low specificity 
would claim that referral bias has increased the prevalence 
of disease in the study group. Therefore, the next question is 
how high would the prevalence of disease in a study popu- 
lation have to be to have a 50% post-test probability of a 
normal arteriogram for a normal thallium test result, i.e., an 
apparent specificity of 50% in the study population. From 
Figure lA, the prevalence of disease would have to be 90% 
and, at that prevalence of disease, the post-test probability 
of having disease for an abnormal thallium test, or apparent 
sensitivity, would approach 99%. The apparent sensitivity in 
the study population, i.e., the post-test probability of disease 
from a positive test, should be nearly perfect because the 
prevalence of disease is so high. Thus, if the true specificity 
of the test was 90% but appeared to be 50% because of 
referral bias affecting the study population. then the preva- 
lence of disease in the study population would have to be 
90% and the post-test probability of disease or the apparent 
sensitivity would have to be 99%. However, prevalence of 
disease in published studies ranges from 55% to 75% and 
sensitivity from 65% to 85%, values inconsistent with the 
hypothesis that true specificity is 90% appearing to be 50% 
because of referral bias in the study population. Therefore, 
the low specificity of 50% cannot be explained by a high 
prevalence of disease produced by referral bias. In addition, 
a large recent study (9) with a sensitivity of 76% and a 
specificity of 49% was not biased by referral selection 
because all 832 subjects, asymptomatic Air Force personnel, 
had coronary arteriograms regardless of thallium exercise 
test results. 
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Figure 1. A, Effects of referral selection bias on increasing preva- 
lence of coronary artery disease (CAD) in the study population for 
testing sensitivity and specificity of a noninvasive test. The ob- 
served data do not fit with a true sensitivity and specificity of 90% 
for thallium stress testing. B, For a disease prevalence of 50% and a 
true sensitivity and specificity of 65% each, reading stress thallium 
images more aggressively to increase post-test probability of disease 
for a positive test, or observed sensitivity, to 80% would cause the 
post-test probability of no disease for a normal test, or observed 
specificity, to fall to 50%, consistent with reported data. 
The present study. On the basis of Figure 1, the preva- 
lence of disease in the study population of Iskandrian et al. 
would have to be 85% to explain their specificity of 62% as 
due to referral bias. However, of 461 patients in their study 
population, 272 were classified as having coronary artery 
disease, a prevalence of only 59%. In their discussion of 
clinical implications, Iskandrian et al. unintentionally dem- 
onstrate the major point here by incorrectly excluding the 
low probability normal group to calculate a disease preva- 
lence of 272 of 330 or 82% in the catheterization group, while 
at the same time including this group as normal as if 
catheterized in the overall complete study. Because the low 
probability group is classified as normal in the study, the true 
prevalence of disease in the study population is 59%. Thus, 
referral bias cannot explain the low specificity of Iskandrian 
et al. because actual disease prevalence of 59% was much 
lower than the prevalence of 85% necessary to explain low 
specificity on this basis. 
The study population with ~5% probability of coronary 
artery disease on which “normalcy rates” of thallium tests 
are calculated (6) is characteristically a younger, more 
vigorous population selected to have few risk factors causing 
coronary artery disease. That younger population is also 
likely to have fewer causes for a false positive thallium stress 
test than would an older group of patients, who have a 
greater risk of coronary artery disease and a greater likeli- 
hood of a false positive exercise test because of differences 
in the anatomy of the older, heavier person, including 
greater chest diameter, greater body mass, bone density, 
greater diaphragmatic and breast attenuation and other fac- 
tors that cause false-positive thallium images. Table III of 
the report of Iskandrian et al. (1) documents the difference in 
body habitus between the low risk normal subjects and the 
group at risk for disease. Therefore, the “normalcy rate” for 
thallium testing from a young population with low probabil- 
ity of disease cannot be extrapolated to the study population 
at risk for coronary artery disease. In this and previous 
reports the uncatheterized low risk normal subjects are used 
as if they had been catheterized, to increase the number of 
patients in the study and to show a favorable “normalcy 
rate” to offset low observed specificity while simultaneously 
classifying this group as uncatheterized to avoid the fact of 
low disease prevalence that disproves referral bias. 
Sensitivity and specificity of the thallium stress test. How 
accurate is thallium stress testing? The answer consistent 
with recently published data is suggested by Figure lB, a 
corresponding graph for a true sensitivity and specificity of 
65% each. Because of the inverse relation between sensitiv- 
ity and specificity, at a disease prevalence of 50%, if images 
were read so as to increase sensitivity to 80% (indicated by 
the upper dashed arrow) then specificity would decrease to 
50% (lower dashed arrow), consistent with published data. If 
images were read so as to give higher specificity, then 
sensitivity would be lower. The net or combined sensitivity- 
specificity data content of thallium stress imaging corre- 
sponds to an approximate equivalent sensitivity and speci- 
ficity of 65% each, where reported sensitivity and specificity 
vary inversely depending on how aggressively or conserva- 
tively abnormalities are called on scans. By conservative or 
aggressive interpretation of images as abnormal, the scan 
reader chooses the preponderance or balance of false posi- 
tive or false negative results but cannot substantially de- 
crease both to clinically acceptable levels. 
How does this analysis@ with higher reported sensitivity 
and specificity in earlier studies? The study populations in 
these early studies consisted of patients undergoing cardiac 
catheterization on clinical grounds. Therefore, these early 
study populations had a higher prevalence and more ad- 
vanced disease than do current study populations in which 
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thallium stress testing is applied to determine whether cath- 
eterization is indicated in the absence of a clear clinical 
diagnosis. Conservative image interpretation in a population 
of high disease prevalence will give reasonably good sensi- 
tivity and specificity as reported in early publications. How- 
ever, conservative image interpretation with the same num- 
ber of false negative and false positive results applied to a 
population of lower disease prevalence (30% to 50%) de- 
creases sensitivity markedly whereas specificity increases. 
To maintain higher sensitivity, the reader then interprets 
images more aggressively, thereby keeping sensitivity high 
but at a cost of decreasing specificity. Therefore, recent 
work showing the same sensitivity but markedly lower 
specificity compared with earlier studies can be explained by 
decreased disease prevalence in the study populations com- 
bined with more aggressive image interpretation. With more 
aggressive interpretations in current lower prevalence study 
populations, 65% sensitivity and 65% specificity become 
skewed to a sensitivity of 80% and specificity of 50% to 60% 
reported in current studies, confirmed by the study (1) of 
Iskandrian et al. and explained by Figure IB. 
Clinical implications. For a sensitivity of 80% as most 
images are currently read, the 60% specificity of thallium 
testing has major medical and economic consequences. With 
use of sensitivity and specificity values of approximately 
65% and 50%, respectively, for exercise electrocardiography 
and 80% and 60% for exercise thallium scintigraphy, the 
efficacy of conventional sequential testing for detecting 
coronary artery disease can be analyzed. In a population 
with 10% to 15% prevalence of coronary disease, as would 
be expected in patients with positive risk factors (13,14), if 
the combination of a positive treadmill electrocardiogram 
(ECG) followed by a confirmatory positive thallium scan 
were required for proceeding to catheterization, 48% of 
patients [ 1 .O-(0.65)(0.8)] with angiographically significant 
coronary artery disease would not be catheterized. If thal- 
lium testing were used in all patients instead of an initial 
exercise ECG exercise test. on/y 18% of the catheterized 
patients w,ould have disease in a population with a preva- 
lence of disease of IO%, calculated as (0.8 x 10) + (0.8 x 10 
t 0.4 X 90). Thus, the low specificity of thallium stress 
testing as recently reported (5-10) and confirmed by the 
study of Iskandrian et al. (11) markedly reduces the clinical 
utility of thallium stress testing in populations of moderate 
prevalence in which a noninvasive test is most needed. In 
addition, Iskandrian et al. have demonstrated that sensitivity 
is highly dependent on achieving maximal exercise stress. 
In contrast, for a noninvasive test with 95% sensitivity 
and 95% specificity as reported for positron emission tomog- 
raphy (15-19). unnecessary cardiac catheterizations are 
largely avoided and severity of coronary artery disease is 
categorized noninvasively (16-20), thereby eliminating fur- 
ther catheterizations in patients having mild disease by 
positron emission tomography suitable for medical manage- 
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ment. This greater accuracy of positron emission tomogra- 
phy has major economic benefits by preventing unnecessary 
catheterizations due to false positive or equivocal thallium 
stress tests that more than compensate for its cost in 
comparison to thallium stress testing, as well as providing 
improved medical management (21). Therefore, serious con- 
sideration should be given to positron emission tomography 
dipyridamole perfusion imaging, which provides sufficiently 
high diagnostic accuracy to substitute for diagnostic coro- 
nary arteriography in many patients 
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